Press Releases
19 September 2017
U.S. ARKRAY, Inc. (ARKRAY) announces the launch of the ADAMS™ A1c HA-8180V System for hemoglobin A1c testing. The system obtained FDA 510(k) clearance as an aid in the diagnosis and monitorin
Read more...16 September 2017
Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims injured by allegedly defective drugs, is commenting on a global recall issued by Medtronic
Read more...15 September 2017
Overlake Medical Center today officially opened its doors to the new Overlake Cancer Center, a $20 million project that transforms the way cancer treatment is delivered to patients. The new Center
Read more...15 September 2017
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, has received approval from the U.S. Food and Drug Administration (FDA) for Ortho's VITROS® Immunodiagnosti
Read more...14 September 2017
As part of the Saudi Vision 2030, The Kingdom of Saudi Arabia has unveiled a comprehensive plan for reform of its entire economic structure. The main goals are to develop other industries and secto
Read more...14 September 2017
Sandata Technologies, LLC, a leading provider of home care agency management solutions, announced today that AccentCare®, Inc., a leader in post-acute home healthcare services has expanded its
Read more...14 September 2017
MedLever, Inc. today announced the launch of a comprehensive agreement with the Hong Kong Sanatorium & Hospital (HKSH) to use the MedLever Platform to enable interoperability and streamline wor
Read more...SmartPractice has received FDA approval for T.R.U.E. TEST (truetest.com) ready-to-use patch test panels for pediatric patients as young as 6 years of age. T.R.U.E. TEST is the only FDA-approved pro
Read more...Vasorum Ltd, following FDA approval of its PMA supplement, the developer and manufacturer of the novel Celt ACD® vascular closure device has added a 7F sized Celt ACD® device to its Celt AC
Read more...12 September 2017
Eli Lilly and Company announced that data across its immunology portfolio will be presented at the annual European Academy of Dermatology and Venereology Congress (EADV), including Phase 2 safety a
Read more...
